Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 58.00
+1.40 (2.47%)
At close: Jan 9, 2026
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 712.71 million as of January 9, 2026. Its market cap has increased by 39.50% in one year.
Market Cap
712.71M
Enterprise Value
681.14M
Revenue
236.21M
Ranking
n/a
PE Ratio
10.60
Stock Price
58.00
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 712.71M, an increase of 33.64%. That is a compound annual growth rate of 1.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 712.71M | 6.04% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 288.83B |
| Novartis AG | 217.97B |
| Galderma Group AG | 39.22B |
| Lonza Group AG | 38.60B |
| Alcon | 31.71B |
| Sandoz Group AG | 26.07B |
| Straumann Holding AG | 15.95B |
| Sonova Holding AG | 12.60B |